Sep. 22, 2023 — A novel drug target has been newly identified ... Scientists Discover a New Way to Help Prevent Breast Cancer 'Time Bomb' Mar. 13, 2023 — Scientists have discovered why breast ...

Abbott Park, Illinois Thursday, May 2, 2024, 15:00 Hrs [IST] ...

The US Food and Drug Administration has approved Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ...

Autoimmune Disorders: Bristol Myers Squibb has entered into a research agreement with Repertoire to develop vaccines for ...

Accord BioPharma, the division of Intas Pharmaceuticals, has secured approval from the US FDA for HERCESSI, a biosimilar to ...

Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves ...

Hercessi marks Accord BioPharma’s first biosimilar to be approved in the United States, with multiple indications for ...

The recent FDA approval of Hercessi expands access to a treatment previously burdened by high costs. Hercessi joins the 5 ...

The approval marks the sixth for a biosimilar referencing Herceptin (trastuzumab) for the treatment of HER2-positive breast ...

X4 Pharmaceuticals said on Monday the U.S. FDA has approved its therapy to treat a rare genetic immunodeficiency disease in patients 12 years of age and older, sending its shares up 16% before the ...

The Food and Drug Administration (FDA ... positive recurrent or metastatic breast cancer. Hercessi is supplied as a 150mg lyophilized powder in a single-dose vial for intravenous infusion after ...

Natural hormone replacement therapy (NHRT) is considered an alternative approach to conventional hormone replacement therapy ...